180 results
Page 5 of 9
6-K
EX-99.1
cd22fy
13 Oct 20
Current report (foreign)
6:15am
6-K
EX-99.1
yzpqwjj791z djdafkm1
30 Sep 20
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
6:00am
6-K
EX-99.1
3b816f7ckn6 vs
28 Sep 20
Current report (foreign)
6:00am
6-K
EX-99.1
91f1wot3ep6cw 0q
25 Sep 20
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
6:05am
6-K
EX-99.1
fw8k9u zmyg953
11 Sep 20
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
6:05am
6-K
EX-99.1
zun4ro2d72ig89s
26 Aug 20
Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress
6:37am
6-K
EX-99.1
rk7s5mjccmc
19 Aug 20
Current report (foreign)
6:00am
6-K
EX-99.2
81nv r7hpz5mcwg
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
ld8rc
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
ghhvg8x
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.1
j5d6kh 3okz22pt5b3
8 Jun 20
Current report (foreign)
6:00am
6-K
EX-99.1
gwi7xpph8kxb5eisyjzu
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.1
awt0pm d2n5
26 May 20
Gilead and Galapagos Announce Positive Topline Results of Phase 2B/3 Trial of Filgotinib In Moderately to Severely Active Ulcerative Colitis
6:10am
6-K
EX-99.1
wizwl0
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.2
ywfkeyr
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
oyrwaho3e9bq60nmclbm
17 Apr 20
Important update to Galapagos’ invitation to its ordinary and extraordinary shareholders’ meetings
6:18am
6-K
EX-99.1
i26mz1qv
16 Apr 20
Galapagos and Ryvu announce research collaboration
6:05am
6-K
EX-99.1
gohd9kgync7om5zmt17
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm